Dr. Paul Dionne

SCOTCH PLAINS, N.J. (PRWEB)
September 16, 2022

NJ Top Dentist, Dr. Paul L. Dionne specializes in general dentistry and full-mouth rehabilitation at his practice, Glen Ridge Dental Arts & North Jersey Dental Sleep Medicine.

Recently, Dr. Dionne became a Diplomate of the American Board of Dental Sleep Medicine.

Dentists who are Diplomates of the ABDSM have demonstrated that they have the skills and knowledge essential for the delivery of excellent patient care.

According to the American Board of Dental Sleep Medicine, “The ABDSM believes higher standards for dental sleep medicine translate into better care for patients and greater accountability. The ABDSM credential is widely recognized as the gold standard for excellence in dental sleep medicine.”

Dr. Paul L. Dionne’s dental practice is founded on the beliefs of active listening and communication with patients. Both of these key principles help Dr. Dionne cultivate strong relationships so he can serve patients to the best of his ability.

Dr. Dionne is also community-oriented and located across the street from Mountainside Medical Hospital, where he serves on the staff overseeing dental residents.

To learn more about Dr. Paul L. Dionne, please visit: https://njtopdocs.com/nj-dentists/paulldionnedmd/

About Us

NJ Top Dentists is a division of NJ Top Docs. NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:

People of all fitness levels are welcome to participate in the 5K Race.

The Running for the Heart event is all about loving your heart and keeping fit while encouraging our communities to develop heart-healthy habits for life — Essence Banks

HOUSTON (PRWEB)
September 15, 2022

Nonprofit group Heart N Hands is holding their third annual “Running for the Heart” 5K Run/Walk/Bike in person on Saturday, September 17, in New Orleans and Houston and virtually, from September 17 – 19. “Running for the Heart” will celebrate Heart N Hands’ eighth year anniversary this year and raise funds to educate girls aged 10-18 about heart health and disease prevention. The 5K’s starting line in New Orleans will be at the Bayou St. John area at Wisner across from Pan Am Stadium in New Orleans. The Houston affiliate will hold its first annual in-person race on September 17, 2022. Due to its popularity in 2020, Heart N Hands will continue its virtual 5K from September 16 to 18. Participants can register for the event at https://www.heartnhands.org.

Heart N Hands started its annual run to further its mission of educating young women on better heart health. “‘Running for the Heart’ 5K is about loving your heart and staying fit during this time to develop great heart-healthy habits for life,” said Founder and President Essence Banks, “Running, walking, and/or biking can bring us together as a community to get our hearts pumping, give to a worthy cause, and allow us to have fun!” The annual race offers the perfect opportunity to get out, enjoy the beautiful weather and show your heart some love.

Heart N Hands ask that everyone who registers for the race complete the 5K (3.1 miles) by foot or on a bike on September 17, then post photos, videos, and stories to their social media tagging #heartnhands and #runningfortheheart to spread the word about the importance of heart health. On top of contributing to a non-profit organization that makes heart health education available to so many young women, Heart N Hands wants to encourage participants to celebrate their personal accomplishments and deepen their love and appreciation for their hearts.

While celebrating Heart N Hand’s 8th anniversary, Running for the Heart helps maintain the focus on fighting the number one killer of women, heart disease. “The Running for the Heart event is all about loving your heart and keeping fit while encouraging our communities to develop heart healthy habits for life,” said Banks, “This year, now more than ever, we have to take charge of our health and get moving. Coming together as a community, virtually or in-person, will empower young girls to get their own hearts pumping and will bring awareness to a great cause.”

Heart N Hands wants to stress that individuals of all fitness levels are welcome to participate. The tax-deductible 5K registration fee is $25 for all participants. Registrants for the in-person 5k will receive plenty of swag (official 5K T-Shirt, water bottle, race bib, and finisher gifts/prizes) at the race location. Virtual 5K participants will have signature t-shirts and goodies mailed to the registered address provided. To learn more about the event or to register, please visit heartnhands.org.

Founded in 2014 by heart disease survivor Essence Harris Banks, Heart N Hands began as a Louisiana nonprofit organization. Since then, the nonprofit has expanded its reach nationally to affiliate chapters in Nashville and Memphis, TN, and is proud to announce its newest affiliate in Houston, TX. Through their Houston outreach, Heart N Hands hopes to continue its mission of educating over 6500 women and their families in partnership with the American Heart Association.

In addition to the annual run, Heart N Hands regularly hosts fitness and wellness sessions full of activities to promote heart health, including Zumba, yoga, high-intensity interval training, and mindfulness meditation. Their partnership with No Kid Hungry led to the creation of “Fruit Friday,” which provided over 400 area children in need with fresh fruit and a dose of heart health education. The nonprofit has also partnered with Girl Scouts Louisiana East to design and offer a “Love Your Heart” patch that over 100 scouts have earned.

The organization aims to promote better heart health in women through its comprehensive, interactive sessions where young women can learn more about taking care of the heart and the specific risk factors for women. These sessions provide instruction on the importance of daily physical activity, heart-healthy cooking demos, grocery store tours, and food label education. CPR training is also a staple of this preventative approach to heart health, in addition to discussing the cardiac impact of smoking, drinking alcohol, and other substance abuse. Heart N Hands has trained over 300 girls in hands-only CPR through their initiatives.

In February, Heart N Hands celebrated American Heart Month with its “Know Your Four” campaign, intended to educate on heart disease’s four major risk factors. The nonprofit also provides scholarship fund awards to graduating High School Seniors in each chapter’s area.

“Heart N Hands has the potential to be a major positive influence on the future women, as our adolescent girls are empowered with awareness and tips for prevention of time sensitive killers – heart disease and stroke. The cycle of premature disease, disability, and death can be broken,” said Sheryl Martin-Schild, MD, PhD, FANA, FAHA, FAAN, Stroke Medical of Neurology & Stroke (Touro Infirmary and New Orleans East Hospital), Director for Louisiana

Emergency Response Network and Heart N Hands Board Member.

Heart N Hands is a nonprofit organization based in New Orleans whose mission is to spread heart health awareness, prevention, and education for young girls in our community. For more information, you can visit https://www.heartnhands.org/.

Share article on social media or email:

Bringing political ideology into clinical practice puts providers in a position of having to violate the most basic standard of care, which is to do no harm.

BOSTON (PRWEB)
September 15, 2022

A Viewpoint published in JAMA Pediatrics asserts that the numerous bills filed in 2021 and 2022 seeking to block access to gender-affirming care for transgender and gender diverse (TGD) adolescents have far-reaching repercussions for clinicians who work in gender-affirming care and for the broader medical community. The potential effects on clinicians include decline in personal health and well-being in addition to professional implications ranging from loss of licensure and income to criminal prosecution. The broader medical community faces the prospect of seeing fewer clinicians enter the field of transgender health as well as a sharp reduction in the current workforce dedicated to providing gender-affirming care.

“Much of the response to these bills, which includes advocacy to defeat them, rightly focuses on the devastating effects they are having on TGD youth and their families,” said senior author Dr. Alex S. Keuroghlian, who directs the National LGBTQIA+ Health Education Center at The Fenway Institute and the Massachusetts General Hospital Psychiatry Gender Identity Program. “In addition, the potential for personal and professional harm to clinicians is significant and should also be a part of this conversation.”

The professional implications of these bans, and the hostile climate they foster, includes harassment and threats of violence. Other professional concerns include the potential for criminal prosecution if clinical practice violates the legal bans on gender-affirming care, the need to hire legal counsel to ensure that clinical care is provided within legal boundaries, potential loss of professional licensure, and loss of income for having to curtail clinical practice or close it altogether.

The greatest effect on clinicians, however, is the moral distress engendered by being constrained from providing care that follows widely accepted pediatric guidelines and knowing that the failure to provide care will likely result in acute mental health crises among their patients.

“Bringing political ideology into clinical practice puts providers in a position of having to violate the most basic standard of care, which is to do no harm,” added Keuroghlian. “Following these laws will require clinicians to violate professional codes of ethics and take action that will almost surely harm the health of their young patients.”

“This push to block access to gender-affirming care may cause some clinicians to leave the field of transgender care altogether and discourage current medical and nursing students, residents, fellows, and other trainees from pursuing careers in transgender health,” said lead author Allysa Warling, B.A. of Harvard Medical School.

The Viewpoint offered three actions to mitigate the potential damage of bills and laws that seek to block access to gender-affirming care:

• 
  Standardize training in gender-affirming care across undergraduate and graduate medical education and all health care professional curricula;
• Disseminate comprehensive, evidence-based clinical guidelines for increasing access to adolescent gender-affirming care; and
• Advocate for protection of adolescent gender-affirming care through state and federal policies beyond the necessary, yet insufficient, statements by health care professional associations.

“Clinician-Level Implications of Bans on Gender-Affirming Medical Care for Youth in the US” was published online by JAMA Pediatrics on August 8, 2022. It is available here.

Share article on social media or email:

“The SYNTap Test fills the void for a highly sensitive and specific clinical diagnostics tool” -Amprion Chief Scientific Officer Claudio Soto, Ph.D.

SAN FRANCISCO (PRWEB)
September 15, 2022

Amprion, a leader in diagnostics for neurodegenerative diseases, invites researchers and practitioners attending MDS to visit Amprion at booth #212. We look forward to discussing how the SYNTap® Biomarker Test addresses the unmet medical need for a validated clinical test to diagnose Parkinson’s disease (PD) and differentiate PD from atypical Parkinson’s at early stages. Accurate and early diagnosis helps accelerate personalized treatment and therapeutic innovations.

The urgent medical need for accurate, early diagnosis of neurodegenerative diseases is growing as the global population ages. For every thousand individuals, 1 to 2 persons are impacted by Parkinson’s. PD’s prevalence increases with age, affecting 1% of the population aged 60 and above. Globally, about 10 million people may be afflicted by PD.

Amprion’s SYNTap Biomarker Test helps physicians diagnose and differentiate complex and often confusing neurodegenerative diseases, including Parkinson’s, Lewy Body Variant of Alzheimer’s Disease, Lewy Body Dementia, Mild Cognitive Impairment with Lewy Bodies, and Multiple System Atrophy. The Company’s proprietary detection technology, Seed Amplification Assay (SAA), accurately detects misfolded α-Synuclein aggregates, a crucial biomarker associated with these devastating conditions.

“The SYNTap Test fills the void for a highly sensitive and specific clinical diagnostics tool,” said Amprion Chief Scientific Officer Claudio Soto, Ph.D., who will speak at Prion2022, September 13-16 in Göttingen, Germany. According to Russ Lebovitz, MD/Ph.D, Amprion CEO, “A confident diagnosis helps optimize personalized treatment and disease management strategies for people living with Parkinson’s and Movement Disorders.” Dr. Lebovitz will attend MDS, International Congress of Parkinson’s Disease and Movement Disorders in Madrid, September 15-18.

Amprion will host a Meet the Expert session in which attendees can discuss scientific insights on how the SYNTap Test performs in a clinical setting.

MEET THE EXPERT – Friday, Sept. 15TH – 10 am to 12 pm – Booth #212

Neurologist Brit Mollenhauer, MD, specializes in Parkinson’s Disease and Movement Disorders and is head of translational research at the Paracelsus-Elena Klinik (PEKK) in Germany. She has developed a study center for clinical trials and translational research and works closely with the Michael J. Fox Foundation for Parkinson’s Research.

“The SAA developed by Amprion offers a highly accurate detection of misfolded Synuclein in cerebrospinal fluid (CSF), which can be diagnostic for patients suspected of having Parkinson’s, Lewy Body Dementia, and Multiple System Atrophy, all of which are Synuclein Aggregation Disorders.”

Dr. Mollenhauer will discuss the value of Amprion’s SYNTap Test in the early identification of Synucleinopathy based on her studies: “We have shown that in one of our patient cohorts with REM Sleep Behavior Disorder (RBD), a prodromal condition for Synuclein Aggregation Disorders, the SYNTap Test can detect misfolded Synuclein at least a decade prior to the time a clinical diagnosis of Synuclein Aggregation Disorders can be made.”

We look forward to connecting with you at MDS booth #212.

Download the SYNTap Test Specification Sheet.

ABOUT AMPRION

A leader in Prion Detection Science™, Amprion innovates biomarker testing for brain diseases. Our SYNTap® Biomarker Test aids in diagnosing Parkinson’s Disease, Lewy Body Dementia, and Lewy Body Variant of Alzheimer’s. Amprion has been granted FDA Breakthrough Device Designation for detecting misfolded Synuclein in CSF. We strive to accelerate personalized medicine for neurodegenerative diseases through molecular testing.

Share article on social media or email:

We hope to make a difference in someone’s life by empowering them to learn about their breast density in hopes of saving their life

LODA, Ill. (PRWEB)
September 15, 2022

Did you know breast density makes it harder to find breast cancer on mammograms and it is a significant risk factor for developing breast cancer? These facts are widely proven yet not commonly known. When found early, breast cancer is curable, but by late stage (stage 4), it is not.

Power Planter, Heidi Punke Brown, and My Density Matters seek to change that together.

“My breast cancer was found at a late stage,” says Heidi Punke Brown, breast cancer thriver and long-time friend of Greg Niewold, owner of Power Planter. “It is my hope that we can spread the word about breast density and early detection so no one else has a diagnosis delayed due to their breast density.”

An estimated 26 million women in the United States with dense breasts are underserved by a mammography alone, leaving those women at risk for breast cancer to grow and spread.

Together with the organization, My Density Matters, grower Abbott-Ipco, Inc, Heidi and Greg created Heidi’s Hope Box to educate people on early breast cancer detection. Each box contains a 3’x 7” pink bulb Power Planter auger, ten (10) pink tulip bulbs, a memoir by Leslie Ferris Yerger (Founder of My Density Matters), a note from Heidi, bulb planting tips, and information on breast density and breast cancer screening. Power Planter will donate $25 from the sale of each $59.99 box to My Density Matters.

“Heidi was the inspiration behind Heidi’s Hope Box,” says Greg Niewold, owner of Power Planter. “Shortly after her diagnosis, I gave her one of our bulb augers so she and her family could plant bulbs as a way of planting hope for her future.”

My Density Matters empowers women to find their breast density, learn their options, and take charge of their breast cancer screening. They are addressing the “how” for earlier diagnosis with an initiative to move from awareness to education to action.

Their Check Your Chart™ initiative empowers women to obtain their mammogram report from their online patient portal, learn their breast density, communicate with their doctor(s) about the results, and collaborate on additional screening options to find cancer earlier by providing them with tools for more informed conversations.

“We hope to make a difference in someone’s life by empowering them to learn about their breast density in hopes of saving their life,” added Niewold.

Pick up a Heidi’s Hope Box here. Contact Stacey Pierson for interviews: stacey@gardenmediagroup.com or 610-444-3040.

Power Planter is a third-generation, family-owned auger company located on a centennial farm in rural Illinois. Our founder, Wayne Niewold, invented the first garden-friendly earth auger more than 30 years ago, and now we manufacture and sell more than 25 sizes and models.

Share article on social media or email: